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BACKGROUND
Healthcare workers (HCWs) often disagree with caregivers or parents about whether, when,
and how to disclose HIV serostatus to perinatally HIV-infected children, yet the critical ethical,
moral, and legal issues involved and their interplay have been underexplored. The purpose of
this article is to bring attention to this increasingly important issue and the complexities
involved, and to provide a framework for considering disclosure-related challenges.
Worldwide, 2.2 million children live with HIV, with 640,000 infected each year.1 In the U.S.,
more than 9,000 children live with perinatal HIV.2 Early in the epidemic, when HIV-infected
children faced very short life expectancies, few providers were concerned about disclosing the
diagnosis to children. However, since the advent of antiretrovirals (ARVs) and their use in
children, increasing numbers of HIV-infected children are living longer, often into adolescence
and young adulthood. Thus, children are reaching a level of cognitive development that allows
them to understand their HIV diagnosis and to participate in treatment decisions, which could
affect adherence to often complex medication regimens. Furthermore, older children and
adolescents are reaching a level of physical and emotional development that can lead to sexual
activity and sexual transmission risks. Sexual transmission is of particular concern among
adolescents who may have little sexual experience, and thus be less familiar with safer sexual
practices. If perinatally infected youth are nonadherent, they could potentially transmit drug-
resistant virus. Thus, providers or other legal guardians/caregivers or parents (all of whom we
will refer to below as “parents”) of children with perinatally acquired HIV face the difficult
tasks of someday telling their child that he or she is HIV infected.
Disclosure of HIV entails telling children that they have a potentially life-threatening,
stigmatized, and sexually transmittable illness. Thus, parents and healthcare providers often
disagree about the timing and appropriateness of disclosure. The American Academy of
Pediatrics (AAP) recommends that all adolescents know their HIV status and that disclosure
be considered for school-age children as soon as is developmentally appropriate.3 However,
the AAP provided few concrete guidelines to support providers and families in this process
(that is, when and how exactly to tell, how to decide, how to weigh psychosocial effects of
disclosure, and whether full disclosure is ever not appropriate).
When disagreements occur about whether to disclose — most commonly when a health-care
worker (HCW) recommends that a child be told, and the parent refuses — critical ethical issues
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surface. Even when parents and HCWs might concur that the time is right to begin discussing
HIV with the child, questions can still arise as to how to disclose — for example, what exactly
should be said. Clinicians often need help with these issues, and guidelines for both parents
and providers can be helpful. There is little clear guidance.
Commonly, parents delay disclosure until children are at least 10 years old, providing some
information about the illness beforehand, without using the terms “HIV” or “AIDS.”4 One
study, for example, reports that 50 percent of staff, caregivers, and patients thought disclosure
should occur before age 12.5 Prior research has reported that some parents try to protect their
children by attributing the need for medical care to other, more benign, or less stigmatized
conditions (for example, asthma or cancer). When full disclosure does occur, the psychological
impact on the child and family is not clear. In fact, studies results differ dramatically as to
whether a higher incidence of psychological and behavioral problems occur among children
who have not been told about their diagnosis versus children who have been formally told.6
Moreover, critical questions emerge of not just how clinicians are addressing these issues, but
how clinicians should proceed in these cases. How should clinicians think about balancing the
rights of the child versus the mother, especially as children grow older? Do the rights of the
child ever trump those of the parent, and if so, when and why? Who should disclose the
diagnosis to the child? One study found that the majority of patients thought they were told at
the right time and by the right person, if the latter were a family member, rather than a healthcare
provider.7
The broader implications of nonadherence, sexual transmission of HIV, and sexual
transmission of drug=-resistant strains of the virus necessitate thorough analysis and
understanding of these issues. Consideration of these ethical dilemmas varies with the
circumstance of the case, and in particular, as we shall see, may shift over time due to
psychological, medical, and social developments. Hence, this article explores these areas by
presenting a clinically based case to illustrate these considerations in disclosure decision
making, and outline the complex issues involved.
Several recent general approaches and theoretical perspectives may be applicable here. Fins
and colleagues have suggested models of “clinical pragmatism,” drawing on the work of John
Dewey, in which in any particular clinical ethical dilemma, both principles and the details of
the particular case are considered.8 Similarly, Dubler has recently suggested approaching
ethical conflicts in clinical care using a “mediation model,” in which, briefly, a “mediator
facilitates a discussion between and among the parties . . . to identify their goals . . . and to
generate . . . options.”9 In addition, the American Counseling Association (ACA) has advocated
a seven-step ethical decision-making model incorporating the work of several researchers,10
that suggests, in brief: (a) identifying the problem, (b) referring to and applying the ACA “Code
of Ethics,” if relevant, (c) determining the nature and dimensions of the dilemma, (d) generating
potential courses of action, (e) considering the potential consequences of all options and
determining action, (f) evaluating the selected course of action to see if it presents any new
ethical considerations, and (g) implementing the course of action.11 Such approaches have not
been applied to these cases, and we have tried to do so below.
A SAMPLE CASE
We present the following case scenario to illustrate many of these dilemmas. This case is drawn
from clinical experience that our team has had. The names and other potentially identifying
details of the case have been changed to protect the identity of the patient and her mother.
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Maria, a 36-year-old HIV-infected Latino woman, gave birth to an HIV-infected daughter,
Amelia. Maria does not want Amelia to know that either of them has HIV. Amelia is now 10
years old. Amelia has been told she takes medications for “a problem in her blood.” Recently,
Amelia says she does not like taking the medication, and occasionally misses doses. The clinic
staff have raised the issue of whether Amelia should be told about her diagnosis. In the near
future, she will be at the age at which girls often become more interested in boys or sexual
behavior. Also, her social worker feels that if Amelia knew her diagnosis, she might be more
adherent to her medications.
But Maria says that she absolutely does not want her daughter to know. Maria believes Amelia
is still too young, and will be emotionally devastated. Maria says that it is her responsibility
— and only her responsibility — as a mother to “protect” her child and that her daughter is
“not ready” to know. Maria says that Amelia is “a good girl” and will not be sexually active
until she is married.
The social worker thinks Maria feels very guilty about having transmitted the virus to her
daughter. Maria herself became infected through a former boyfriend, who had a history of
intravenous-drug use. Still, the staff is concerned and thinks Maria should begin to reconsider.
The staff thus confronted several ethical dilemmas. Does the daughter have a right to know
her diagnosis? Does the mother have a right not to disclose the diagnosis to the daughter? Does
a mother have a right to the privacy of her own diagnosis, which could be threatened if her
daughter learns of her own status? Should the staff ever tell the daughter if the mother does
not want them to? If the daughter wants to know more about her condition, what should the
staff say? Should she still be told simply that she has “a blood disease”? Are there other
approaches the staff can take, and if so, what?
This case is typical of many. Parents often fear that disclosure may distress the child and other
family members. Healthcare providers often advocate disclosure, due to the possible
psychological and medical benefits for the child, as well as public health concerns (that is, the
possibility of transmission to sexual partners).
Legally, there is no clear mandate concerning most of these disclosure dilemmas. Federal and
state laws do not appear to address diagnosis disclosure to children explicitly. Many state laws
do protect the privacy of information regarding a person’s HIV status, except in very specific
circumstances;12 and these laws may prevent HCWs from informing a child that he or she was
perinatally infected with HIV, as such a disclosure would result in violating the confidentiality
of the mother’s HIV diagnosis. In at least one state (that is, Georgia) a physician may be
warranted in telling a child that he or she was perinatally HIV infected, as the law supports a
physician’s disclosure of a mother’s HIV diagnosis to a child, given reasonable belief that the
child is at risk of being HIV infected.13
Other laws that address the rights of a child versus the rights of a parent are worth noting.
Generally, laws assume that parents act in the best interests of the child. The law might thus
support a parent’s decision regarding disclosure. But the law recognizes that in certain
circumstances, and for various reasons, parents may not act in their child’s best interest.
According to the principle of parens patriae, protection of the child’s welfare outweighs the
parents’ right to refuse medical treatment for the child,14 though whether parents nonetheless
have a right to refuse disclosure to a child is unclear. The Storar case set a precedent that a
parent cannot deprive a child from life saving treatment.15 Similarly, Article 10 of the N.Y.
State Family Court Act established a legal procedure to protect children from physical, mental,
and emotional mistreatment. However, parents often consent to treatment, but to not disclosure
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to an HIV-infected child. Whether nondisclosure alone ever constitutes mistreatment is
debatable. Other legal precedents have granted adolescents some treatment-related autonomy.
Adolescents may petition courts for “emancipated minor” status to be eligible for healthcare
coverage, or may qualify for “mature minor” status that allows older children who understand
the associated risks and benefits to initiate certain treatments without parental consent when
parental consent may be difficult to obtain.16 Yet the case of McChandless v. State suggested
that physicians should not treat a minor without parental consent when the parents are available
within one week, during which time treatment delay would not alter the outcome.17 In all states,
an adolescent infected with a sexually transmitted disease (STD) such as syphilis can receive
treatment without parental notification, but other STDs differ from HIV, since in some states
decisions about parental notification for STD services is at physicians’ discretion.18 Yet clearly
these precedents refer to treatment, not disclosure.
When children are in foster care, only some foster care parents — especially those who have
a medical foster home — have legal rights concerning the child’s healthcare. Typically, foster
care agencies assume responsibility for the child’s healthcare, and often require consent from
biological parents (or the court) before children receive specialized care. Yet how this
responsibility and consent apply to disclosure, and how healthcare teams can best address
disclosure to children in foster care, is not clear. The AAP states that test results “should be
provided by the child’s physician to foster parents, biological parents (if possible), foster care
agency and the child (if old enough to comprehend and if disclosure is appropriate to the
developmental level of the child).” But this organization does not say when or how foster
parents should disclose when the child inquires before being old enough to understand the
diagnosis,19 or when the child is old enough.
In short, in facing dilemmas concerning disclosures to children, given the absence of other
legal guidance, HCWs must make difficult ethical decisions.
As depicted in table 1, numerous sets of ethical issues arise both for and against disclosure and
need to be considered and weighed — related broadly to principles of autonomy, beneficence,
nonmalfeasance, and justice. For each of these principles, reasons exist both pro and con.
Hence, the specifics of each case play important roles in balancing these issues. These broad
categories of concerns overlap, but we use them here to structure and clarify the discussion.
The principle of autonomy might dictate that Amelia has a right to know her diagnosis. Yet
ethically, minors are capable of giving assent, but not consent,20 and parents have certain rights
and responsibilities over their children’s care. Reasons to disclose include the notion that a
child has a right to know what is occurring in his or her own body, yet Maria, as a mother,
might be said to have autonomy as a parent, with rights to challenge healthcare providers’
suggestions. Maria has the responsibility to make decisions about what is in Amelia’s best
interest, and thus has the right not to disclose the diagnosis to her daughter if no imminent
danger exists. Moreover, arguably, Maria has the right potentially to withdraw Amelia from
care (if to do so is not imminently life threatening to Amelia).
The principle of beneficence arises here, since disclosure could increase the child’s sense of
autonomy, empowering the child, and facilitating his or her ability to care for him or herself.
Knowledge of his or her status could help a child feel more control over certain issues
concerning his or her self. Potentially, children who are aware of their status will also not be
as angry or resentful about having been kept in ignorance as those who learn only at a later
point in their lives.
Yet the ideal of nonmalfeasance might suggest that children have a right to be protected from
harsh and painful information that is otherwise not necessary, and hence should not be told of
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their status. Since the infection did not result from the child’s behavior, the child should be
protected from the psychological and social burdens of this disease, if possible.
Principles of beneficence and nonmalfeasance may be relevant, too, based on medical
implications of disclosure decisions. Disclosure may21 or may not22 improve children’s
medication adherence. This difference in findings may be due to various factors, for example,
caregiver stress, cognitive functioning,23 or age of the child.24 Among other chronic conditions
(for example, diabetes and asthma), nonadherence increases as children age.25 If medication
needs to be taken in public, stigma can hamper adherence.26 Nonadherence may result, too,
from parents giving adolescents “too much” responsibility for taking medications, after
disclosure. Adolescents may also have difficulty considering the long-term consequences of
nonadherence, or may not want to take their medication because it reminds them that they are
“not normal,” or it might result in unintended disclosure to peers.
Psychologically, too, disclosure can be beneficial and reduce harm. HIV-infected youth who
have not been told of their infection may encounter anxiety and related emotional and
behavioral problems, sensing that “something is wrong.” Disclosure could thus alleviate some
anxiety, and facilitate addressing these worries, since fears of the utterly unknown can be
greater than those of a known disease. Disclosure may be helpful, too, by facilitating
psychotherapy that can address HIV-related mental health issues, since HIV can then be
discussed more directly and openly, rather than hidden. Knowledge of their HIV infection may
enable adolescents to cope better with the disease and possible fears of death from HIV.
Children unaware of their chronic health condition may experience more anxiety.27
Yet disclosure can potentially cause psychological harm, as children may not be equipped to
handle the implications of disclosure. Modified labeling theory provides a means to
understanding some of the psychosocial consequences that might result from disclosure to
children: prior to learning of their HIV status, children may have internalized societal
conceptions of the meaning of being HIV infected (that is, as associated with risky sex or drug
injection).28 Thus, when children learn they are HIV infected, they may need to integrate their
previous identity (of being HIV negative) with a new one (of being HIV positive). As they
cope with the news of how they became infected, they may have to reconceptualize their
mother’s and/or father’s identity as well. Modified labeling theory suggests that negative labels
lead to negative outcomes for the person labeled. When children expect that they will receive
negative labels or stigma for being HIV positive, they may respond in several ways, including
secrecy, which is likely to be encouraged by some care-givers to avoid stigmatization. Such
children may try to avoid any indication that they are different from their peers. HIV-infected
children may withdraw or keep a comfortable distance from others who are known to be
infected. Infected children may choose to spend their free time only with their family, who
may actually encourage such isolation. Or, some HIV-infected children may affiliate with each
other through treatment groups, but avoid being close to other children. Yet secrecy and
withdrawal can lead to isolation, in turn fostering poor self-esteem and mental health problems,
including depression. Alternatively, some children may want to divulge their diagnosis within
their social networks to educate others or gain acceptance. This may result in increased support
or, conversely, ostracization.29 Disclosure might further marginalize a child already
marginalized due to race, socioeconomic status, or HIV-related disabilities, or promote a false
sense of friendships and social support.
Cognitively, children may lack the capacity to understand HIV and its implications, in which
case disclosure may cause harm. Many children younger than 10 have less fully developed
abilities to understand abstract concepts of having a chronic illness, especially if they do not
feel ill.30
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Parents face additional ethical concerns as well. As mentioned earlier, the principle of
autonomy would indicate that parents or legal guardians have the right to decide when to
disclose to a child, because they may know best when exactly a child is prepared. They will
also have to deal with the consequences. But to give caregivers unequivocal authority over
disclosure might not always be best, since caregivers might not know or be able to do what is
best for their child. Their fears that their child will get angry at them, or that parental sexual
or drug use risk behaviors will be disclosed could interfere with their objectivity in considering
their child’s best interests. HIV-infected parents may also have cognitive or mental health
problems that impair their judgment.
Medically, the potential benefits and harms of disclosure on maternal health behaviors have
been underexplored. After disclosure, a parent may decrease his or her sense of responsibility
for medical monitoring of the child. Yet divulgence of a child’s HIV-positive status may also
increase tensions due to revelations of prior parental secrets. Psychologically, disclosure to a
child may benefit the parent, reducing the burden of keeping the secret, and facilitate support
and caregiving. Disclosure may also enhance communication and connectedness between the
parent and child, since previously the parent withheld information from the child and may have
devoted energy to maintaining secrecy. However, following disclosure, if the child divulges
the information to others, stigma can increase for the parent and family, adding stress, and
possibly fueling maternal guilt, self-hatred, and low self-esteem. Parents may become
overwhelmed or burdened by the child’s consequent distress. Disclosure could also lead to
subsequent divulgence of additional family secrets that parents would prefer remain hidden
(for example, concerning a parent’s drug use or sexual behavior).
A moral perspective might argue that the child would only need to know his or her status if he
or she is sexually active, and because the child should be abstinent anyway, there is no reason
to tell.
Given all of the above considerations and fears that Maria could remove Amelia from their
medical care, the staff decided that if Maria did not want Amelia to know, they should not
disclose at this time. Rather, they decided to delay disclosure, while working with Maria to
determine the best time to move forward with the disclosure process. The staff also decided
that if Amelia asked, they would refrain from answering, and instead discuss a plan with Maria,
since they felt they should never lie about the diagnosis if Amelia inquired about it. Amelia
did not ask for additional information about her “blood disease.”
PART II
Amelia is now 13 years old. She says that many girls she knows have boyfriends, but she denies
that she is dating or romantically involved.
The staff again become concerned, and speak with Maria about telling Amelia, but Maria still
refuses to disclose. Maria doesn’t want to upset her daughter whom, she feels, seems very well-
adjusted. She had spoken to her priest who said that she has a right not to tell Amelia. The staff
decide to continue to accede to the mother’s wishes.
Six months later, Amelia tells her doctor that she has a boyfriend, but denies having sex.
Additional questions now arise as to whether the staff should tell Amelia at this point. Does a
13 year old have a greater right to know than a 10 year old? The staff wrestles with whether
Amelia is sexually involved or likely to be in the imminent future.
When a child becomes sexually active, the presence of a third party — the sexual partner—
introduces additional complexity into disclosure decisions. Here, the well-being of a third party
— the daughter’s sexual partner, if one exists — is potentially at stake. The possible harm
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caused by nondisclosure could now involve the transmission of HIV to the potential sexual
partner, since if the adolescent is aware of being HIV infected, he or she may be more likely
to engage in safer sex (that is, using condoms). Although safer sex is by no means guaranteed
following disclosure, an adolescent who is unaware of his or her HIV infection lacks this critical
information, which can potentially help motivate prevention behaviors. Maria may have the
right to make decisions about her daughter’s well-being, but not the well-being of a boyfriend,
if one exists. The staff question whether to believe Amelia that she has not had sex, and decide
to believe her, in part because of mutual trust developed over the years. The team thus decides
again to respect Maria’s decision not to tell, but to continue to encourage Maria to move toward
full disclosure.
PART III
Amelia is now 15 years old and has a boyfriend, and tells her doctor that she has had sex with
him, but does not always use condoms. The physician decides not to break Amelia’s
confidentiality about sexual activity, but tells Maria that it is time for Amelia to know her
diagnosis, because Amelia is getting older and is at an age where many girls are sexually active
and that she could endanger her partner. Maria objects to disclosure and says that Amelia goes
to church regularly with her and would not have sex at this age.
The staff then wrestle with whether they should tell Amelia that she is HIV infected, in order
to enable her to make informed decisions about whether or not she will expose her boyfriend
to the sexual transmission of HIV. Should the staff encourage Amelia to inform her mother
that she is sexually active, so that Maria would be more inclined to let Amelia be told about
HIV? Or should the staff tell Maria that Amelia is sexually active, and then attempt to encourage
her to inform Amelia of her HIV status? What rights, if any, does the boyfriend have here?
Ethically, the staff should tell Amelia at this point, though the issues here may still be complex.
In particular, Amelia may not want to inform or protect the boyfriend. Disclosure alone may
be beneficial in decreasing risky behavior — unsafe sex or substance use. However, youth with
HIV may hesitate to use condoms, fearing that they will be seen as “unclean” by partners. Some
have likely reached a level of moral development31 to want to avoid transmitting HIV to others.
However, that desire may conflict with their wish to enhance or maintain their own
psychosocial well-being or acceptance, or to appear “normal.” Additionally, disclosure might
cause harm, since children may then feel angry about their HIV status, and have diminished
hope for their future, leading to risky behavior without much concern about possible
transmission to others, as has similarly been suggested among adults.32 For children with
AIDS-related neurological impairments, care-givers and providers need to pay attention to the
child’s own emerging sexual curiosity and interest, ability to read social cues, and social
judgment, when considering what information is appropriate to provide, given the child’s level
of impairment.33 These determinations can be complicated, since HIV can also cause
“adolescent-onset dementia,” with problems in processing speed, memory, executive planning,
and judgment34 that can contribute to transmission of the disease through sexual activity.35
On balance, the staff decide at this point to inform Amelia of her HIV status and of the risk
that she may have already transmitted HIV to her boyfriend, or could do so in the future if she
continued having unprotected sex. They talk with Amelia about her concerns about telling her
boyfriend, and help her to think about encouraging him to get an HIV test (for example,
suggesting that they could go together to get tested for HIV) and to use condoms in the future.
The staff inform Maria that they think that these discussions are important at this point. Maria,
though with some reluctance, finally agrees to staff disclosure.
Amelia was very sad for a few weeks, and then grew angry with Maria for not having told her
sooner. Amelia intimated that she always knew something was wrong, but was too afraid to
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ask anyone about it. Maria became concerned that Amelia had started to drink alcohol with
her friends and to smoke marijuana.
PART IV
Two months later, Amelia tells her physician that she has not informed her boyfriend that she
is HIV infected. She says she doesn’t want to tell him because she is ashamed and fears that
he will “dump her” if she tells him.
The staff then have to decide what obligation they have to inform the boyfriend that he may
have been exposed to HIV. They think they could either tell him or work closely with Amelia
to have her inform him or encourage him to get tested and use condoms. The staff wonder if
Maria has the right to know that her daughter is putting him at risk, and what obligation Maria
has to keep Amelia from endangering him.
Here, the physician could choose to inform the boyfriend. A Tarasoff-like “duty to warn”
permits HCWs in some states to notify sexual partners whom an HIV-infected patient is likely
to have exposed.36 As of 1999, 31 states had laws regarding partner notification37 and
Tarasoff “duty to warn” obligations, though these differ — for example, concerning
criminalization of HIV-infected individuals who do not disclose to sexual partners —whether
laws refer to “exposure alone” versus resultant infection of others, presence or absence of
intent, and degrees of criminality involved (that is, from misdemeanor to attempted murder).
Some states prohibit an HIV-infected person from engaging in any sexual activity with an HIV-
uninfected person without disclosing, while others prohibit only unprotected penetrative acts.
38 In New York and many other states, legally, such disclosure to the boyfriend is currently at
the doctor’s discretion. Physicians can tell, but questions still emerge as to whether to do so is
in the best interests of the adolescent if she opposes such notification. She may then lose trust
in her providers (since her partner may say that he was notified, and he may trace the situation
to her). Healthcare providers could also work with Amelia and refer her to a partner-notification
program.39
DISCUSSION
The exploration presented in this article illustrates how a wide range of ethical principles and
other issues arise and need to be taken into consideration and balanced in this case. Yet to
weigh these competing pros and cons can be difficult. Ordinarily, the mother’s rights to
autonomy trump those of the child, since the latter is a minor — if the mother is thought to be
acting in the best interest of the child. This analysis illustrates the difficulty of developing
definitive “one-size-fits-all” guidelines for these complex scenarios. Each case must be
evaluated based on the specifics of the situation, consideration of the full range of concerns
presented here, and the potential consequences of all options. Such an approach permits needed
flexibility.
We have attempted to present the principles that should be followed when providers confront
ethical dilemmas regarding disclosure of a child’s HIV diagnosis. Though the articulation of
specific, unequivocal rules is impossible, the range of principles highlighted here need to be
considered and weighed. Though a utilitarian approach might suggest that the decision should
maximize the greatest good for the greatest number, that determination is tricky at best, since
the interests of the parties may conflict, and nondisclosure has significant public health
consequences. This analysis also elucidates how moral, potentially theological, not just ethical,
issues are involved. This analysis suggests potential limits of this ethical framework as well.
Specifically, these principles can potentially be interpreted in varying ways that can be
subjective and lead in different directions.
Klitzman et al. Page 8













Clinically, some centers are no doubt more experienced than others in approaching, addressing,
and following up on these issues (for example, assessing whether decisions had the anticipated
effect and consequences). Hence, appropriate training for confronting these issues, and
involvement of nursing staff, social workers, and psychologists is critical.
Clinicians can aid with disclosure issues in several important ways. First, providers can help
parents think about disclosure as a process, rather than a single event or point in time. In this
regard, caregivers may require education about the possibility of partial disclosure — gradually
increasing the child’s understanding over time. Parents may also benefit from peer support,
speaking with other caregivers concerning disclosure to an HIV-infected child — either
individually or in a group.40 The staff can try to work closely with the parent to optimize trust
and minimize potential distrust that may exist. The staff may want to discuss with the mother
the findings that it is best for the parent-child relationship if the parent embarks on the disclosure
process at some point in the near future, rather than wait until a later point (for example, at age
18 when the provider can disclose to the child without the parent’s permission). At that later
point, the child might resent the mother for not having previously divulged the information.
Nonetheless, even if told by 10 or 11 years, the child may still regret not being told earlier. The
staff could encourage and assist the mother to develop a future plan for disclosing. When the
mother realizes the need to disclose at a concrete point in the future, she may be more inclined
to overcome some hesitation or denial regarding the ultimate need for disclosure. The staff
might determine whether and what other family secrets exist (for example, concerning maternal
drug use, history of trading sex for drugs or money, extramarital sexual relationships,
bisexuality in a father) that may underlie or contribute to the mother’s current desire for
continued secrecy concerning HIV, or if the caregiver is concerned about ostracism, loss of
housing or jobs, et cetera, that might result if the child discloses to others. Social workers and
psychologists have skills that can help the parent cope with these issues. Unfortunately, HIV
is still highly stigmatized, given its association with disenfranchised groups and sexual and
drug risk behaviors, and potential lethality. Once disclosure has occurred, children often benefit
from interactions with other HIV-infected children who are aware of their diagnosis to discuss
coping and future disclosures with others.
Policy makers need to be acutely aware of the questions and nuances involved pertaining to
HIV disclosure. Tensions arise if the child is psychologically and cognitively — but not legally
— old enough to be told. The staff may then arguably, from a purely ethical perspective, be
supported in disclosing, but legally be unable to disclose. Hence, potentially, policy makers
could consider broadening the concept of emancipated or mature minor so that clinicians can
more fully discuss the infection with offspring, even if parents object. Potentially, state laws
could also become more uniform, and allow for the development of national guidelines that
are more universally applicable.
This case also highlights particular questions for future research. Future studies can explore
the ways children and parents view and approach these issues, and weigh these often-competing
considerations; the conflicts families and providers have encountered; and their decision-
making processes. Parents and clinicians no doubt vary in how they weigh some of these
concerns more than others. In certain cases clinicians might think that some of these issues are
more pertinent than others. Similar topics needing further investigation are whether disclosures
to children at particular ages increase or decrease adherence and safer sexual practices,41 and
when disclosure to children can potentially harm or benefit maternal health behaviors. This
case highlights the need to develop new models for assessing and supporting children’s
comprehension of HIV-related information as they age. Future studies can also elucidate
children’s ability to keep such information secret.
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Cultural issues are potentially critical here as well, given the ethnic diversity of families
affected by HIV. A family’s cultural background might influence decisions concerning
disclosure of an HIV diagnosis to a child.42 Cultures vary in their views and practices
concerning discussions of personal or taboo topics. A culturally sensitive, multi-disciplinary
care approach tailored to an adolescent’s needs and social circumstances is vital — using
culturally sensitive language, and clear and effective interpretation.43
Given the growing numbers of pediatric HIV cases worldwide, there is a tremendous need for
greater understanding and guidance regarding these issues. These concerns are rapidly
spreading in the developing world, where issues of autonomy, rights and responsibilities,
shame, and secrecy may be framed differently. The substantial stigma in many countries can
result in considerable ostracism and isolation of people living with HIV. Research is needed
to understand how these issues manifest themselves in different cultural contexts.
We have attempted to shed critical light on the dilemmas posed by disclosure of HIV infection
to perinatally infected children and adolescents. Given the rising spread of the pandemic,
increased attention to these complexities — how ethical, psychological, medical, and legal
concerns can at times conflict and need to be carefully and sensitively assessed — is critical.
This attention can enhance patient care and health policy, and will be of ever-rising significance
in upcoming years.
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Table 1
Ethical Principles Involved in Disclosure of HIV Status to a Minor
Principle Arguments in Favor of Disclosure Arguments Against Disclosure
Autonomy • Child has a right to know what is inside his or her own
body
• Parent has a right to decide
• Parent will have to deal with consequences of
disclosure
• Parents generally act in the child’s best interest
• Rights of parent outweigh those of HCW
Beneficence • Disclosure may empower the child
• Disclosure may have medical benefits:
– Helping with adherence
– Encouraging/increasing safer sexual
practices
– Helping mothers adherence and healthcare
• Disclosure may have psychological benefits:
– Increasing use of psychotherapy/social
services by mother and child
– Reducing burden of secrecy for parents
– Enhancing relationships and bonding
between parent and child
• Disclosure can facilitate parent receiving additional
help from HCWs
• Non-disclosure provides some benefit, protecting
child from burden
Non-Malfeasance • Disclosure can prevent deception of child • Disclosure may cause medical harms:
– Decreasing adherence
• Disclosure may:
– Burden the child psychologically,
impairing self-esteem, and increasing
anxiety and depression
– Increase marginalization/stigma of child
and family
– Cause parents to feel guilty
• Child might then disclose the information to others,
hurting the family as a whole
Additional Issues that arise if a minor is sexually active
Autonomy • Sexual partner has a right to know of his or her risk • Offspring has a right to decide whether to disclose or
not to partner
Beneficence • Disclosure might prompt safer sex
Non-Malfeasance • Withholding of information can contribute to partner
becoming infected
Justice • Public health concerns:
– Offspring may have additional partners
over time to whom he or she can spread HIV
– Sexual partners have a right to know risks
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